Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Gabriella Ferrandina
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Concepts & Ideas
Procedures
Chemicals & Drugs
Physiology
Sign-in to see full Profile
Network (preview)
181
Scambia, Giovanni
72
Mancuso, Salvatore
37
Benedetti Panici, Pierluigi
36
Zannoni, Gian Franco
33
Ranelletti, Franco
29
Legge, Francesco
24
Distefano, Mariagrazia
23
Testa, Antonia Carla
20
Fagotti, Anna
20
Lorusso, Domenica
19
Salutari, Vanda
16
Ludovisi, Manuela
16
Martinelli, Enrica
16
Fruscella, Erika
15
Fanfani, Francesco
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Gabriella Ferrandina (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Testa A C; Ludovisi M; Manfredi R; Zannoni G; Gui B; Basso D; Di Legge A; Licameli A; Di Bidino R; Scambia G; Ferrandina G
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2009;34(3):335-44.
-
2009: Pignata Sandro; Ferrandina Gabriella; Scarfone Giovanna; Scollo Paolo; Odicino Franco; Cormio Gennaro; Katsaros Dionyssios; Frigerio Luigi; Mereu Liliana; Ghezzi Fabio; Manzione Luigi; Lauria Rossella; Breda Enrico; Alletti Desiderio Gueli; Ballardini Michela; Vernaglia Alessandra; Sorio Roberto; Tumolo Salvatore; Musso Pietro; Magni Giovanna; Pisano Carmela; Morabito Alessandro
Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.
Critical reviews in oncology/hematology 2009;71(3):233-41.
-
2009: Battaglia Alessandra; Buzzonetti Alexia; Baranello Cinzia; Ferrandina Gabriella; Martinelli Enrica; Fanfani Francesco; Scambia Giovanni; Fattorossi Andrea
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer.
Cancer immunology, immunotherapy : CII 2009;58(9):1363-73.
-
2009: Fanfani Francesco; Fagotti Anna; Ferrandina Gabriella; Raspagliesi Francesco; Ditto Antonino; Cerrotta Anna Maria; Morganti Alessio; Smaniotto Daniela; Scambia Giovanni
Neoadjuvant chemoradiation followed by radical hysterectomy in FIGO Stage IIIB cervical cancer: feasibility, complications, and clinical outcome.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(6):1119-24.
-
2009: Deodato Francesco; Macchia Gabriella; Grimaldi Luca; Ferrandina Gabriella; Lorusso Domenica; Salutari Vanda; Cilla Savino; Valentini Vincenzo; Cellini Numa; Piermattei Angelo; Scambia Giovanni; Morganti Alessio Giuseppe
Stereotactic radiotherapy in recurrent gynecological cancer: a case series.
Oncology reports 2009;22(2):415-9.
-
2009: Draisci Gaetano; Frassanito Luciano; Pinto Raffaella; Zanfini Bruno; Ferrandina Gabriella; Valente Alessio
Safety and effectiveness of coadministration of intrathecal sufentanil and morphine in hyperbaric bupivacaine-based spinal anesthesia for cesarean section.
Journal of opioid management 2009;5(4):197-202.
-
2009: Ferrandina Gabriella; Petrillo Marco; Bonanno Giuseppina; Scambia Giovanni
Targeting CD133 antigen in cancer.
Expert opinion on therapeutic targets 2009;13(7):823-37.
-
2009: Rutella Sergio; Bonanno Giuseppina; Procoli Annabella; Mariotti Andrea; Corallo Maria; Prisco Maria Grazia; Eramo Adriana; Napoletano Chiara; Gallo Daniela; Perillo Alessandro; Nuti Marianna; Pierelli Luca; Testa Ugo; Scambia Giovanni; Ferrandina Gabriella
Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(13):4299-311.
-
2009: Miceli Fiorella; Ranelletti Franco O; Martinelli Enrica; Petrillo Marco; Scambia Giovanni; Navarra Pierluigi; Ferrandina Gabriella
Expression and subcellular localization of CRH and its receptors in human endometrial cancer.
Molecular and cellular endocrinology 2009;305(1-2):6-11.
-
2009: De Vincenzo Rosa; Amadio Giulia; Ricci Caterina; Licameli Angelo; Ferrandina Gabriella; Capelli Giovanni; Scambia Giovanni
Treatment of cervical cancer in Italy: strategies and their impact on the women.
Vaccine 2009;27 Suppl 1():A39-45.
-
2009: Testa Antonia Carla; Licameli Angelo; Di Legge Alessia; Mascilini Floriana; Petruzziello Lucio; Pelagalli Mauro; Scambia Giovanni; Ferrandina Gabriella
Color Doppler sonographic features of a Krukenberg tumor in pregnancy.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2009;28(5):695-8.
-
2009: Testa A C; Gaurilcikas A; Licameli A; Di Stasi C; Lorusso D; Scambia G; Ferrandina G
Sonographic imaging of urinoma.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2009;33(4):490-1.
-
2009: Testa A C; Gaurilcikas A; Licameli A; Mancari R; Di Legge A; Malaggese M; Mascilini F; Zannoni G F; Scambia G; Ferrandina G
Sonographic features of primary ovarian fibrosarcoma: a report of two cases.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2009;33(1):112-5.
-
2009: Morganti Alessio G; Cilla Savino; Valentini Vincenzo; Digesu' Cinzia; Macchia Gabriella; Deodato Francesco; Ferrandina Gabriella; Cece M Grazia; Cirocco Massimo; Garganese Giorgia; Di Lullo Liberato; Traficante Divina; Scarabeo Francesca; Panunzi Simona; De Gaetano Andrea; Sallustio Giuseppina; Cellini Numa; Sofo Luigi; Piermattei Angelo; Scambia Giovanni
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;90(1):86-92.
-
2009: Ferrandina Gabriella; Martinelli Enrica; Petrillo Marco; Prisco Maria Grazia; Zannoni Gianfranco; Sioletic Stefano; Scambia Giovanni
CD133 antigen expression in ovarian cancer.
BMC cancer 2009;9():221.
-
2008: Ferrandina Gabriella; Martinelli Enrica; Petrillo Marco; Prisco Maria Grazia; Zucconi Adriana; Santaguida Salvatore; Zannoni Gianfranco; Scambia Giovanni; Ferlini Cristiano
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients.
Gynecologic oncology 2008;111(2):237-43.
-
2008: Distefano Mariagrazia; Riccardi Silvia; Capelli Giovanni; Costantini Barbara; Petrillo Marco; Ricci Caterina; Scambia Giovanni; Ferrandina Gabriella
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy.
Gynecologic oncology 2008;111(1):144-50.
-
2008: Ferrandina Gabriella; Petrillo Marco; Zannoni Gian Franco; Testa Antonia; Sioletic Stefano; Scambia Giovanni
A case of isolated ovarian recurrence from vulvar carcinoma.
Archives of gynecology and obstetrics 2008;278(4):393-6.
-
2008: Muscolini Michela; Cianfrocca Roberta; Sajeva Angela; Mozzetti Simona; Ferrandina Gabriella; Costanzo Antonio; Tuosto Loretta
Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells.
Molecular cancer therapeutics 2008;7(6):1410-9.
-
2008: Cellini Numa; Smaniotto Daniela; Scambia Giovanni; Luzi Stefano; Balducci Mario; Ferrandina Gabriella; Corvari Barbara; Margariti Pasquale A; Valentini Vincenzo; D'Agostino Giuseppe
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study.
American journal of clinical oncology 2008;31(3):280-4.
-
2008: Ferrandina G; Petrillo M; Carbone A; Zannoni G; Martinelli E; Prisco M; Pignata S; Breda E; Savarese A; Scambia G
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients.
British journal of cancer 2008;98(12):1910-5.
-
2008: Pignata Sandro; Breda Enrico; Scambia Giovanni; Pisano Carmela; Zagonel Vittorina; Lorusso Domenica; Greggi Stefano; De Vivo Rocco; Ferrandina Gabriella; Gallo Ciro; Perrone Francesco
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.
Critical reviews in oncology/hematology 2008;66(3):229-36.
-
2008: Savelli L; Ceccarini M; Ludovisi M; Fruscella E; De Iaco P A; Salizzoni E; Mabrouk M; Manfredi R; Testa A C; Ferrandina G
Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2008;31(5):560-6.
-
2008: Ferrandina Gabriella; Ludovisi Manuela; Corrado Giacomo; Carone Vito; Petrillo Marco; Scambia Giovanni
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer.
Gynecologic oncology 2008;109(2):187-93.
-
2008: Ferrandina G; Bonanno G; Pierelli L; Perillo A; Procoli A; Mariotti A; Corallo M; Martinelli E; Rutella S; Paglia A; Zannoni G; Mancuso S; Scambia G
Expression of CD133-1 and CD133-2 in ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(3):506-14.
-
2008: Ferrandina Gabriella; Ludovisi Manuela; Lorusso Domenica; Pignata Sandro; Breda Enrico; Savarese Antonella; Del Medico Pietro; Scaltriti Laura; Katsaros Dionyssios; Priolo Domenico; Scambia Giovanni
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):890-6.
-
2008: Testa A C; Mancari R; Di Legge A; Mascilini F; Salutari V; Scambia G; Ferrandina G
The 'lead vessel': a vascular ultrasound feature of metastasis in the ovaries.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2008;31(2):218-21.
-
2008: Battaglia Alessandra; Buzzonetti Alexia; Monego Giovanni; Peri Laura; Ferrandina Gabriella; Fanfani Francesco; Scambia Giovanni; Fattorossi Andrea
Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer.
Immunology 2008;123(1):129-38.
-
2008: Ferrandina Gabriella; Fanfani Francesco; Ludovisi Manuela; Fagotti Anna; Carbone Arnaldo; Zannoni Gianfranco; Guerriero Massimiliano; Petrillo Marco; Scambia Giovanni
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation?
Gynecologic oncology 2008;108(1):220-5.
-
2008: Legge Francesco; Petrillo Marco; Adamo Vincenzo; Pisconti Salvatore; Scambia Giovanni; Ferrandina Gabriella
Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome.
BMC cancer 2008;8():367.
-
2008: Pignata Sandro; Ferrandina Gabriella; Scarfone Giovanna; Scollo Paolo; Odicino Franco; Cormio Gennaro; Katsaros Dionyssios; Villa Antonella; Mereu Liliana; Ghezzi Fabio; Manzione Luigi; Lauria Rossella; Breda Enrico; Alletti Desiderio Gueli; Ballardini Michela; Lombardi Alessandra Vernaglia; Sorio Roberto; Mangili Giorgia; Priolo Domenico; Magni Giovanna; Morabito Alessandro
Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study.
BMC cancer 2008;8():252.
-
2008: Ferrandina Gabriella; Salutari Vanda; Petrillo Marco; Carbone Arnaldo; Scambia Giovanni
Conservatively treated glassy cell carcinoma of the cervix.
World journal of surgical oncology 2008;6():92.
-
2008: Ferrandina Gabriella; Macchia Gabriella; Legge Francesco; Deodato Francesco; Forni Franca; Digesù Cinzia; Carone Vito; Morganti Alessio G; Scambia Giovanni
Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
Oncology 2008;74(1-2):42-9.
-
2007: Forni Franca; Ferrandina Gabriella; Deodato Francesco; Macchia Gabriella; Morganti Alessio G; Smaniotto Daniela; Luzi Stefano; D'Agostino Giuseppe; Valentini Vincenzo; Cellini Numa; Giardina Bruno; Scambia Giovanni
Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness.
International journal of radiation oncology, biology, physics 2007;69(4):1145-9.
-
2007: Ferrandina G; Legge F; Fagotti A; Fanfani F; Distefano M; Morganti A; Cellini N; Scambia G
Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures.
Gynecologic oncology 2007;107(1 Suppl 1):S127-32.
-
2007: Ferrandina G; Scambia G; Legge F; Petrillo M; Salutari V
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B.
Gynecologic oncology 2007;107(1):154-6.
-
2007: Ferrandina G; Ludovisi M; De Vincenzo R; Salutari V; Lorusso D; Colangelo M; Prantera T; Valerio M R; Scambia G
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(8):1348-53.
-
2007: Ferrandina Gabriella; Legge Francesco; Mey Valentina; Nannizzi Sara; Ricciardi Simona; Petrillo Marco; Corrado Giacomo; Scambia Giovanni
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge.
Cancer chemotherapy and pharmacology 2007;60(3):459-61.
-
2007: Pignata S; Scambia G; Pisano C; Breda E; Di Maio M; Greggi S; Ferrandina G; Lorusso D; Zagonel V; Febbraro A; Riva N; De Rosa V; Gallo C; Perrone F;
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group.
British journal of cancer 2007;96(11):1639-43.
-
2007: Testa A C; Ferrandina G; Timmerman D; Savelli L; Ludovisi M; Van Holsbeke C; Malaggese M; Scambia G; Valentin L
Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2007;29(5):505-11.
-
2007: Testa A C; Timmerman D; Exacoustos C; Fruscella E; Van Holsbeke C; Bokor D; Arduini D; Scambia G; Ferrandina G
The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2007;29(5):512-6.
-
2007: Ferrandina Gabriella; Perillo Alessandro; Distefano Mariagrazia; D'Agostino Giuseppe; Gallotta Valerio; Pierelli Luca; Scambia Giovanni
Carboplatin-based neoadjuvant treatment with peripheral blood stem cell and growth factor support in locally advanced cervical cancer patients with bulky metastatic lymph nodes.
European journal of obstetrics, gynecology, and reproductive biology 2007;131(2):236-8.
-
2007: Lorusso Domenica; Ferrandina Gabriella; Fanfani Francesco; Gagliardi Maria Lucia; Scambia Giovanni
Investigational agents against platinum-resistant ovarian cancer.
Expert opinion on investigational drugs 2007;16(3):325-36.
-
2007: Ferrandina Gabriella; Distefano Mariagrazia; Ludovisi Manuela; Morganti Alessio; Smaniotto Daniela; D'Agostino Giuseppe; Fanfani Francesco; Scambia Giovanni
Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy.
Annals of surgical oncology 2007;14(3):1129-35.
-
2007: Legge F; Eaton D; Molife R; Ferrandina G; Judson I; de Bono J; Kaye S
Participation of patients with gynecological cancer in phase I clinical trials: two years experience in a major cancer center.
Gynecologic oncology 2007;104(3):551-6.
-
2007: Ferrandina Gabriella; Carbone Arnaldo; Zannoni Gian Franco; Martinelli Enrica; Testa Antonia Carla; Gallotta Valerio; De Ninno Maria; Scambia Giovanni
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma.
The journal of obstetrics and gynaecology research 2007;33(1):95-9.
-
2007: Ferrandina Gabriella; Martinelli Enrica; Zannoni Gian Franco; Distefano Mariagrazia; Paglia Amelia; Ferlini Cristiano; Scambia Giovanni
Expression of class III beta tubulin in cervical cancer patients administered preoperative radiochemotherapy: correlation with response to treatment and clinical outcome.
Gynecologic oncology 2007;104(2):326-30.
-
2007: Lorusso D; Ferrandina G; Pagano L; Gagliardi M L; Scambia G
Successful pregnancy in stage IE primary non-Hodgkin's lymphoma of uterine cervix treated with neoadjuvant chemotherapy and conservative surgery.
Oncology 2007;72(3-4):261-4.
-
2007: Ferrandina G; Zannoni G F; Martinelli E; Vellone V; Prisco M G; Scambia G
Endometrial carcinoma recurring as carcinosarcoma: report of two cases.
Pathology, research and practice 2007;203(9):677-81.
-
2007: Ferrandina Gabriella; Zannoni Gian Franco; Petrillo Marco; Vellone Valerio; Martinelli Enrica; Scambia Giovanni
Glassy cell carcinoma of the endometrium: a case report and review of the literature.
Pathology, research and practice 2007;203(4):217-20.
-
2006: Ferrandina Gabriella; Distefano Mariagrazia; Smaniotto Daniela; Morganti Alessio; Paglia Amelia; Macchia Gabriella; Corvari Barbara; Lorusso Domenica; Scambia Giovanni
Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
Gynecologic oncology 2006;103(2):500-5.
-
2006: Ferrandina Gabriella; Legge Francesco; Salutari Vanda; Paglia Amelia; Testa Antonia; Scambia Giovanni
Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations.
European journal of cancer (Oxford, England : 1990) 2006;42(14):2296-302.
-
2006: Fagotti Anna; Ferrandina Gabriella; Fanfani Francesco; Ercoli Alfredo; Lorusso Domenica; Rossi Marco; Scambia Giovanni
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.
Annals of surgical oncology 2006;13(8):1156-61.
-
2006: Legge F; Ferrandina G; Scambia G
From bio-molecular and technology innovations to clinical practice: focus on ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii46-8.
-
2006: Ferrandina Gabriella; Zannoni Gian Franco; Martinelli Enrica; Paglia Amelia; Gallotta Valerio; Mozzetti Simona; Scambia Giovanni; Ferlini Cristiano
Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2774-9.
-
2006: Ferrandina Gabriella; Ranelletti Franco Oreste; Legge Francesco; Salutari Vanda; Martinelli Enrica; Fattorossi Andrea; Lorusso Domenica; Zannoni Gianfranco; Vellone Valerio; Paglia Amelia; Scambia Giovanni
Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 1):2055-60.
-
2006: Graziani Grazia; Ferrandina Gabriella; Pozzoli Giacomo; Vergati Matteo; Muzi Alessia; Legge Francesco; Tentori Lucio; Scambia Giovanni; Navarra Pierluigi
Corticotropin-releasing hormone receptor-1 in human endometrial cancer.
Oncology reports 2006;15(2):375-9.
-
2006: Testa A C; Ludovisi M; Savelli L; Fruscella E; Ghi T; Fagotti A; Scambia G; Ferrandina G
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2006;27(1):65-70.
-
2006: Pignata Sandro; Ferrandina Gabriella; Scarfone Giovanna; Scollo Paolo; Odicino Franco; Selvaggi Luigi; Katsaros Dionyssios; Frigerio Luigi; Mereu Liliana; Ghezzi Fabio; Manzione Luigi; Lauria Rossella; Breda Enrico; Marforio Giovanna; Ballardini Michela; Lombardi Alessandra Vernaglia; Sorio Roberto; Tumolo Salvatore; Costa Bruno; Magni Giovanna; Perrone Francesco; Favalli Giuseppe;
Extending the platinum-free interval with a non-platinum therapy in platinum-sensitive recurrent ovarian cancer. Results from the SOCRATES Retrospective Study.
Oncology 2006;71(5-6):320-6.
-
2006: Ferrandina Gabriella; Ranelletti Franco O; Martinelli Enrica; Paglia Amelia; Zannoni Gian Franco; Scambia Giovanni
Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer.
BMC cancer 2006;6():182.
-
2006: Ferrandina Gabriella; Salutari Vanda; Testa Antonia; Zannoni Gian Franco; Petrillo Marco; Scambia Giovanni
Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: a case report and review of the literature.
BMC cancer 2006;6():169.
-
2005: Testa Antonia C; Fruscella Erika; Ludovisi Manuela; De Vincenzo Rosa; Malaggese Marinella; Corrado Giacomo; Basso Danila; Scambia Giovanni; Ferrandina Gabriella
The role of sonographic examination in the follow-up of gynecological neoplasms.
Gynecologic oncology 2005;99(3):696-703.
-
2005: Lorusso D; Ferrandina G; Fruscella E; Marini L; Adamo V; Scambia G
Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(6):1002-13.
-
2005: Fruscella E; Testa A C; Ferrandina G; De Smet F; Van Holsbeke C; Scambia G; Zannoni G F; Ludovisi M; Achten R; Amant F; Vergote I; Timmerman D
Ultrasound features of different histopathological subtypes of borderline ovarian tumors.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2005;26(6):644-50.
-
2005: Ferrandina G; Distefano M; Ludovisi M; Fagotti A; Fanfani F; Scambia G
Assessment of pathological status of lower pelvic nodes to tailor surgery in not squamous early cervical carcinoma.
Gynecologic oncology 2005;99(1):246-7.
-
2005: Fanfani Francesco; Fagotti Anna; Ferrandina Gabriella; Bifulco Giuseppe; Legge Francesco; Lorusso Domenica; Minelli Luca; Scambia Giovanni
Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis.
Human reproduction (Oxford, England) 2005;20(10):2964-8.
-
2005: Ferrandina G; Zannoni G F; Gallotta V; Foti E; Mancuso S; Scambia G
Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report.
Gynecologic oncology 2005;99(1):215-7.
-
2005: Testa Antonia Carla; Ferrandina Gabriella; Fruscella Erika; Van Holsbeke Caroline; Ferrazzi Enrico; Leone Francesco P G; Arduini Domenico; Exacoustos Caterina; Bokor Daniela; Scambia Giovanni; Timmerman Dirk
The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2005;24(9):1267-78.
-
2005: Ferrandina Gabriella; Ranelletti Franco Oreste; Gallotta Valerio; Martinelli Enrica; Zannoni Gian Franco; Gessi Marco; Scambia Giovanni
Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
Gynecologic oncology 2005;98(3):383-9.
-
2005: Ferrandina Gabriella; Paris Ida; Ludovisi Manuela; D'Agostino Giuseppe; Testa Antonia; Lorusso Domenica; Zanghi Mariangela; Pisconti Salvatore; Pezzella Giuseppa; Adamo Vincenzo; Breda Enrico; Scambia Giovanni
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival.
Gynecologic oncology 2005;98(2):267-73.
-
2005: Ferrandina G; Testa A C; Zannoni G F; Poerio A; Scambia G
Skull metastasis in primary vulvar adenocarcinoma of the Bartholin's gland: a case report.
Gynecologic oncology 2005;98(2):322-4.
-
2005: Ferrandina G; Lorusso D; Longo R; Testa A C; Scambia G
Pegylated liposomal doxorubicin in platinum-treated recurrent or metastatic cervical carcinoma.
Gynecologic oncology 2005;98(2):332-3.
-
2005: Smaniotto Daniela; D'Agostino Giuseppe; Luzi Stefano; Valentini Vincenzo; Macchia Gabriella; Mantini Giovanna; Margariti Pasquale Alessandro; Ferrandina Gabriella; Scambia Giovanni
Concurrent 5-fluorouracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome.
Tumori 2005;91(4):295-301.
-
2005: Testa A C; Ajossa S; Ferrandina G; Fruscella E; Ludovisi M; Malaggese M; Scambia G; Melis G B; Guerriero S
Does quantitative analysis of three-dimensional power Doppler angiography have a role in the diagnosis of malignant pelvic solid tumors? A preliminary study.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2005;26(1):67-72.
-
2005: Corrado Giacomo; Ercoli Alfredo; Ferrandina Gabriella; Scambia Giovanni
Re: A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment by P. Morice et al.
Gynecologic oncology 2005;98(1):175; author reply 176.
-
2005: Smaniotto Daniela; D'Agostino Giuseppe; Luzi Stefano; Valentini Vincenzo; Macchia Gabriella; Mangiacotti Maria Grazia; Margariti Pasquale Alessandro; Ferrandina Gabriella; Scambia Giovanni
Concurrent 5-fluorouracil, mitomycin C and radiation, with or without brachytherapy, in recurrent endometrial cancer: a scoring system to predict clinical response and outcome.
Tumori 2005;91(3):215-20.
-
2005: Legge F; Ferrandina G; Salutari V; Scambia G
Biological characterization of ovarian cancer: prognostic and therapeutic implications.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv95-101.
-
2005: Ferrandina Gabriella; Distefano Mariagrazia; Testa Antonia; De Vincenzo Rosa; Scambia Giovanni
Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review.
Gynecologic oncology 2005;97(2):693-6.
-
2005: Perillo A; Ferrandina G; Pierelli L; Bonanno G; Scambia G; Mancuso S
Stem cell-based treatments for gynecological solid tumors.
European review for medical and pharmacological sciences 2005;9(2):93-102.
-
2005: Ercoli A; Ferrandina G; Genuardi M; Zannoni G F; Cicchillitti L; Raspaglio G; Carrara S; Mancuso S; Scambia G
Microsatellite instability is not related to response to cisplatin-based chemotherapy in cervical cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(2):308-11.
-
2005: Mozzetti Simona; Ferlini Cristiano; Concolino Paola; Filippetti Flavia; Raspaglio Giuseppina; Prislei Silvia; Gallo Daniela; Martinelli Enrica; Ranelletti Franco Oreste; Ferrandina Gabriella; Scambia Giovanni
Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):298-305.
-
2005: Ferrandina G; Legge F; Martinelli E; Ranelletti F O; Zannoni G F; Lauriola L; Gessi M; Gallotta V; Scambia G
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters.
British journal of cancer 2005;92(2):271-7.
-
2004: Lorusso D; Ferrandina G; Lo Voi R; Fagotti A; Scambia G
Role of pegylated liposomal doxorubicin (PLD) in epithelial ovarian cancer.
Journal of chemotherapy (Florence, Italy) 2004;16 Suppl 4():98-103.
-
2004: Fruscella E; Testa A C; Ferrandina G; Manfredi R; Zannoni G F; Ludovisi M; Malaggese M; Scambia G
Sonographic features of decidualized ovarian endometriosis suspicious for malignancy.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2004;24(5):578-80.
-
2004: Ferrandina Gabriella; Zannoni Gian F; Ranelletti Franco O; Legge Francesco; Gessi Marco; Salutari Vanda; Gallotta Valerio; Lauriola Libero; Scambia Giovanni
Cyclooxygenase-2 expression in borderline ovarian tumors.
Gynecologic oncology 2004;95(1):46-51.
-
2004: Perillo A; Ferrandina G; Pierelli L; Rutella S; Mancuso S; Scambia G
Cytokines alone for PBPC collection in patients with advanced gynaecological malignancies: G-CSF vs G-CSF plus EPO.
Bone marrow transplantation 2004;34(8):743-4.
-
2004: Testa A C; Ferrandina G; Distefano M; Fruscella E; Mansueto D; Basso D; Salutari V; Scambia G
Color Doppler velocimetry and three-dimensional color power angiography of cervical carcinoma.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2004;24(4):445-52.
-
2004: Zannoni Gian Franco; Gallotta Valerio; Legge Francesco; Tarquini Elisabetta; Scambia Giovanni; Ferrandina Gabriella
Pseudo-Meigs' syndrome associated with malignant struma ovarii: a case report.
Gynecologic oncology 2004;94(1):226-8.
-
2004: Testa Antonia Carla; Mansueto Donata; Lorusso Domenica; Fruscella Erika; Basso Danila; Scambia Giovanni; Ferrandina Gabriella
Angiographic power 3-dimensional quantitative analysis in gynecologic solid tumors: feasibility and reproducibility.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2004;23(6):821-8.
-
2004: Ferrandina Gabriella; Ranelletti Franco Oreste; Legge Francesco; Gessi Marco; Salutari Vanda; Distefano Maria Grazia; Lauriola Libero; Zannoni Gian Franco; Martinelli Enrica; Scambia Giovanni
Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3117-23.
-
2004: Savelli Luca; Testa Antonia Carla; Ferrandina Gabriella; De Iaco Pierandrea; Rosati Federica; Ghi Tullio; Basso Danila; Scambia Giovanni
Pelvic relapses of uterine neoplasms: transvaginal sonographic and Doppler features.
Gynecologic oncology 2004;93(2):441-5.
-
2004: Fattorossi Andrea; Battaglia Alessandra; Ferrandina Gabriella; Coronetta Ferdinando; Legge Francesco; Salutari Vanda; Scambia Giovanni
Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma.
Cancer 2004;100(7):1418-28.
-
2004: Ferrandina Gabriella; Ranelletti Franco Oreste; Salutari Vanda; Gessi Marco; Legge Francesco; Zannoni Gian Franco; Scambia Giovanni; Lauriola Libero
Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions.
Gynecologic oncology 2004;92(2):537-44.
-
2004: Fagotti Anna; Ferrandina Gabriella; Fanfani Francesco; Legge Francesco; Lauriola Libero; Gessi Marco; Castelli Paola; Barbieri Fabrizio; Minelli Luca; Scambia Giovanni
Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters.
Human reproduction (Oxford, England) 2004;19(2):393-7.
-
2004: Fattorossi Andrea; Battaglia Alessandra; Ferrandina Gabriella; Buzzonetti Alessia; Legge Francesco; Salutari Vanda; Scambia Giovanni
Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients.
Gynecologic oncology 2004;92(1):106-15.
-
2004: Lorusso D; Naldini A; Testa A; D'Agostino G; Scambia G; Ferrandina G
Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients. May a new treatment schedule improve toxicity profile?
Oncology 2004;67(3-4):243-9.
-
2004: Distefano Mariagrazia; Ferrandina Gabriella; Smaniotto Daniela; Margariti Alessandro Pasquale; Zannoni Gianfranco; Macchia Gabriella; Manfredi Riccardo; Mangiacotti Maria Grazia; Cellini Numa; Scambia Giovanni
Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility.
Oncology 2004;67(2):103-11.
-
2003: Battaglia Alessandra; Ferrandina Gabriella; Buzzonetti Alessia; Malinconico Paolo; Legge Francesco; Salutari Vanda; Scambia Giovanni; Fattorossi Andrea
Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire.
Immunology 2003;110(3):304-12.
-
2003: Ferrandina Gabriella; Ranelletti Franco Oreste; Lauriola Libero; Zannoni Gian Franco; Legge Francesco; Gessi Marco; Salutari Vanda; Scambia Giovanni
Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer.
Oncology reports 2003;10(6):1799-804.
-
2003: Fruscella Erika; Gallo Daniela; Ferrandina Gabriella; D'Agostino Giuseppe; Scambia Giovanni
Gemcitabine: current role and future options in the treatment of ovarian cancer.
Critical reviews in oncology/hematology 2003;48(1):81-8.
-
2003: Ferrandina Gabriella; Ranelletti Franco O; Legge Francesco; Lauriola Libero; Salutari Vanda; Gessi Marco; Testa Antonia C; Werner Ulrike; Navarra Pierluigi; Tringali Giuseppe; Battaglia Alessandra; Scambia Giovanni
Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4324-31.
-
2003: D'Agostino G; Ferrandina G; Ludovisi M; Testa A; Lorusso D; Gbaguidi N; Breda E; Mancuso S; Scambia G
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer.
British journal of cancer 2003;89(7):1180-4.
-
2003: Lorusso D; Ferrandina G; Greggi S; Gadducci A; Pignata S; Tateo S; Biamonte R; Manzione L; Di Vagno G; Ferrau' F; Scambia G;
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(7):1086-93.
-
2003: Ferlini Cristiano; Raspaglio Giuseppina; Mozzetti Simona; Distefano Mariagrazia; Filippetti Flavia; Martinelli Enrica; Ferrandina Gabriella; Gallo Daniela; Ranelletti Franco Oreste; Scambia Giovanni
Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance.
Molecular pharmacology 2003;64(1):51-8.
-
2003: Marana Elisabetta; Scambia Giovanni; Maussier Maria L; Parpaglioni Raffaella; Ferrandina Gabriella; Meo Francesco; Sciarra Mario; Marana Riccardo
Neuroendocrine stress response in patients undergoing benign ovarian cyst surgery by laparoscopy, minilaparotomy, and laparotomy.
The Journal of the American Association of Gynecologic Laparoscopists 2003;10(2):159-65.
-
2003: Ercoli A; Fagotti A; Malzoni M; Ferrandina G; Susini T; Malzoni C; Scambia G
Radiofrequency bipolar coagulation for radical hysterectomy: technique, feasibility and complications.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13(2):187-91.
-
2003: Testa Antonia Carla; Ciampelli Mario; Mastromarino Carmen; Lopez Rossella; Zannoni Gianfranco; Ferrandina Gabriella; Scambia Giovanni
Intratumoral color Doppler analysis in endometrial carcinoma: is it clinically useful?
Gynecologic oncology 2003;88(3):298-303.
-
2003: Ferrandina Gabriella; Pierelli Luca; Perillo Alessandro; Rutella Sergio; Ludovisi Manuela; Leone Giuseppe; Mancuso Salvatore; Scambia Giovanni
Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):195-200.
-
2003: Ferrandina G; Ranelletti F O; Legge F; Lauriola L; Poerio A; Zannoni G F; Smaniotto D; Margariti P A; Macchia G; Scambia G
Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery.
International journal of radiation oncology, biology, physics 2003;55(1):21-7.
-
2003: Fanfani Francesco; Ferrandina Gabriella; Corrado Giacomo; Fagotti Anna; Zakut Haim Vito; Mancuso Salvatore; Scambia Giovanni
Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage IIIc ovarian cancer patients.
Oncology 2003;65(4):316-22.
-
2003: Raspaglio G; Ferrandina G; Ferlini C; Scambia G; Ranelletti F O
Epidermal growth factor-responsive laryngeal squamous cancer cell line Hep2 is more sensitive than unresponsive CO-K3 one to quercetin and tamoxifen apoptotic effects.
Oncology research 2003;14(2):83-91.
-
2003: Testa Antonia Carla; Pomini Francesco; Fattorossi Andrea; Battaglia Alessandra; Ferrandina Gabriella; Mansueto Donata; Mastromarino Carmen; Scambia Giovanni; Caruso Alessandro
Doppler velocimetry and cytofluorimetric analysis in uterine myomas.
Gynecologic and obstetric investigation 2003;56(3):139-42.
-
2002: Gallo Daniela; Ferrandina Gabriella; Giacomelli Sabrina; Fruscella Erika; Zannoni GianFranco; Morazzoni Paolo; Riva Antonella; Bombardelli Ezio; Mancuso Salvatore; Scambia Giovanni
Dietary soy modulation of biochemical parameters in DMBA-induced mammary tumors.
Cancer letters 2002;186(1):43-8.
-
2002: Ferrandina G; Lauriola L; Zannoni G F; Distefano M G; Legge F; Salutari V; Gessi M; Maggiano N; Scambia G; Ranelletti F O
Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications.
British journal of cancer 2002;87(10):1145-52.
-
2002: Ferrandina Gabriella; Legge Francesco; Ranelletti Franco O; Zannoni Gian F; Maggiano Nicola; Evangelisti Antonella; Mancuso Salvatore; Scambia Giovanni; Lauriola Libero
Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome.
Cancer 2002;95(4):801-7.
-
2002: Ferrandina G; Lauriola L; Zannoni G F; Fagotti A; Fanfani F; Legge F; Maggiano N; Gessi M; Mancuso S; Ranelletti F O; Scambia G
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(8):1205-11.
-
2002: Fagotti Anna; Ferrandina Gabriella; Longo Romina; Mancuso Salvatore; Scambia Giovanni
Minilaparotomy in early stage endometrial cancer: an alternative to standard and laparoscopic treatment.
Gynecologic oncology 2002;86(2):177-83.
-
2002: Ceccaroni Marcello; D'Agostino Giuseppe; Ferrandina Gabriella; Gadducci Angiolo; Di Vagno Giovanni; Pignata Sandro; Poerio Antonella; Salerno Maria Giovanna; Fanucchi Antonio; Lapresa Maria Teresa; Tambaro Rosa; Scambia Giovanni
Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study.
Gynecologic oncology 2002;85(3):445-50.
-
2002: Ferrandina G; Ranelletti F O; Lauriola L; Fanfani F; Legge F; Mottolese M; Nicotra M R; Natali P G; Zakut V H; Scambia G
Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.
Gynecologic oncology 2002;85(2):305-10.
-
2002: D'Agostino Giuseppe; Distefano Mariagrazia; Greggi Stefano; Salerno MariaGiovanna; Ferrandina Gabriella; Poerio Antonella; Mancuso Salvatore; Scambia Giovanni
Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin.
Cancer chemotherapy and pharmacology 2002;49(3):256-60.
-
2002: Ferrandina G; Lauriola L; Distefano M G; Zannoni G F; Gessi M; Legge F; Maggiano N; Mancuso S; Capelli A; Scambia G; Ranelletti F O
Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):973-81.
-
2002: D'Agostino Giuseppe; Ferrandina Gabriella; Garganese Giorgia; Salerno M Giovanna; Lorusso Domenica; Farnetano M Giuseppina; Mancuso Salvatore; Scambia Giovanni
Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer.
Oncology 2002;62(2):110-4.
-
2001: Giannice R; Susini T; Ferrandina G; Poerio A; Margariti P A; Carminati R; Marana E; Mancuso S; Scambia G
Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients.
Cancer 2001;92(10):2562-8.
-
2001: Scambia G; Ferrandina G; Distefano M; Fagotti A; Manfredi R; Zannoni G F; Mancuso S
Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients?
Gynecologic oncology 2001;83(2):319-24.
-
2001: Gallo D; Giacomelli S; Cantelmo F; Zannoni G F; Ferrandina G; Fruscella E; Riva A; Morazzoni P; Bombardelli E; Mancuso S; Scambia G
Chemoprevention of DMBA-induced mammary cancer in rats by dietary soy.
Breast cancer research and treatment 2001;69(2):153-64.
-
2001: Cantuaria G; Fagotti A; Ferrandina G; Magalhaes A; Nadji M; Angioli R; Penalver M; Mancuso S; Scambia G
GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy.
Cancer 2001;92(5):1144-50.
-
2001: Ferrandina G; Ranelletti F O; Larocca L M; Maggiano N; Fruscella E; Legge F; Santeusanio G; Bombonati A; Mancuso S; Scambia G
Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(9):2656-61.
-
2001: Salerno M G; Ferrandina G; Greggi S; Pierelli L; Menichella G; Leone G; Scambia G; Mancuso S
High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results.
Bone marrow transplantation 2001;27(10):1017-25.
-
2001: Fattorossi A; Battaglia A; Pierelli L; Malinconico P; Andreocci L; Perillo A; Ferrandina G; Martelli O; Rughetti A; Nuti M; Cortesi E; Scambia G
Effects of granulocyte-colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor administration on T cell proliferation and phagocyte cell-surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantation.
Cancer immunology, immunotherapy : CII 2001;49(12):641-8.
-
2001: Fiumicino S; Ercoli A; Ferrandina G; Hess P; Raspaglio G; Genuardi M; Rovella V; Bellacosa A; Cicchillitti L; Mancuso S; Bignami M; Scambia G
Microsatellite instability is an independent indicator of recurrence in sporadic stage I-II endometrial adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1008-14.
-
2001: Greggi S; Salerno M G; D'Agostino G; Ferrandina G; Lorusso D; Manzione L; Mancuso S; Scambia G
Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancer.
Oncology 2001;60(1):19-23.
-
2000: Lavarino C; Pilotti S; Oggionni M; Gatti L; Perego P; Bresciani G; Pierotti M A; Scambia G; Ferrandina G; Fagotti A; Mangioni C; Lucchini V; Vecchione F; Bolis G; Scarfone G; Zunino F
p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(23):3936-45.
-
2000: Ferrandina G; Stoler A; Fagotti A; Fanfani F; Sacco R; De Pasqua A; Mancuso S; Scambia G
p21WAF1/CIP1 protein expression in primary ovarian cancer.
International journal of oncology 2000;17(6):1231-5.
-
2000: Ferrandina G; Mozzetti S; Marone M; Fagotti A; Macchia G; Mancuso S; Scambia G
Bcl-2, bax, bcl-x(L) and bcl-x(S) expression in neoplastic and normal cervical tissue.
Cancer letters 2000;155(1):19-27.
-
2000: Marone M; Ferrandina G; Macchia G; Mozzetti S; de Pasqua A; Benedetti-Panici P; Mancuso S; Scambia G
Bcl-2, Bax, Bcl-x(L) and Bcl-x(S) expression in neoplastic and normal endometrium.
Oncology 2000;58(2):161-8.
-
2000: Ferrandina G; Filippini P; Ferlini C; Maggiano N; Stoler A B; Fruscella E; Mozzetti S; Mancuso S; Freedman R S; Scambia G; Ranelletti F O
Growth inhibitory effects and radiosensitization induced by fatty aromatic acids on human cervical cancer cells.
Oncology research 2000;12(9-10):429-40.
-
2000: Mozzetti S; Ferrandina G; Marone M; D'Ingiullo F; Fruscella E; De Pasqua A; Mancuso S; Scambia G
Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues.
Cancer detection and prevention 2000;24(6):536-41.
-
1999: Ferrandina G; Fagotti A; Salerno M G; Natali P G; Mottolese M; Maneschi F; De Pasqua A; Benedetti-Panici P; Mancuso S; Scambia G
p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer.
British journal of cancer 1999;81(4):733-40.
-
1999: Foti E; Ferrandina G; Martucci R; Romanini M E; Benedetti Panici P; Testa U; Mancuso S; Scambia G
IL-6, M-CSF and IAP cytokines in ovarian cancer: simultaneous assessment of serum levels.
Oncology 1999;57(3):211-5.
-
1999: Ercoli A; Ferrandina G; Raspaglio G; Marone M; Maggiano N; Del Mastro P; Benedetti Panici P; Mancuso S; Scambia G
hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer.
British journal of cancer 1999;80(10):1665-71.
-
1999: Ferlini C; Scambia G; Marone M; Distefano M; Gaggini C; Ferrandina G; Fattorossi A; Isola G; Benedetti Panici P; Mancuso S
Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines.
British journal of cancer 1999;79(2):257-63.
-
1998: Marone M; Scambia G; Mozzetti S; Ferrandina G; Iacovella S; De Pasqua A; Benedetti-Panici P; Mancuso S
bcl-2, bax, bcl-XL, and bcl-XS expression in normal and neoplastic ovarian tissues.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(2):517-24.
-
1998: Scambia G; Ferrandina G; Distefano M; D'Agostino G; Benedetti-Panici P; Mancuso S
Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer.
Cancer letters 1998;123(2):135-9.
-
1998: Marone M; Scambia G; Giannitelli C; Ferrandina G; Masciullo V; Bellacosa A; Benedetti-Panici P; Mancuso S
Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression.
International journal of cancer. Journal international du cancer 1998;75(1):34-9.
-
1997: Masciullo V; Scambia G; Marone M; Giannitelli C; Ferrandina G; Bellacosa A; Benedetti Panici P; Mancuso S
Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas.
International journal of cancer. Journal international du cancer 1997;74(4):390-5.
-
1997: Ferrandina G; Scambia G; Damia G; Tagliabue G; Fagotti A; Benedetti Panici P; Mangioni C; Mancuso S; D'Incalci M
Glutathione S-transferase activity in epithelial ovarian cancer: association with response to chemotherapy and disease outcome.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):343-50.
-
1997: Scambia G; Masciullo V; Benedetti Panici P; Marone M; Ferrandina G; Todaro N; Bellacosa A; Jain S K; Neri G; Piffanelli A; Mancuso S
Prognostic significance of ras/p21 alterations in human ovarian cancer.
British journal of cancer 1997;75(10):1547-53.
-
1996: Scambia G; Foti E; Ferrandina G; Leone F P; Gadducci A; Benedetti-Panici P; Mancuso S
Prognostic role of immunosuppressive acidic protein in advanced ovarian cancer.
American journal of obstetrics and gynecology 1996;175(6):1606-10.
-
1996: Maurizi M; Almadori G; Ferrandina G; Distefano M; Romanini M E; Cadoni G; Benedetti-Panici P; Paludetti G; Scambia G; Mancuso S
Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma.
British journal of cancer 1996;74(8):1253-7.
-
1996: Marone M; Scambia G; Ferrandina G; Giannitelli C; Benedetti-Panici P; Iacovella S; Leone A; Mancuso S
Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.
British journal of cancer 1996;74(7):1063-8.
-
1996: Scambia G; De Vincenzo R; Ranelletti F O; Panici P B; Ferrandina G; D'Agostino G; Fattorossi A; Bombardelli E; Mancuso S
Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin.
European journal of cancer (Oxford, England : 1990) 1996;32A(5):877-82.
-
1996: Ferrandina G; Scambia G; Marone M; Benedetti Panici P; Giannitelli C; Pernisco S; Coronetta F; Mancuso S
NM23 in Ovarian Cancer. Correlation with clinicopathological and biochemical parameters.
Annals of the New York Academy of Sciences 1996;784():509-12.
-
1996: Scambia G; Benedetti Panici P; Ferrandina G; Distefano M; Salerno G; Romanini M E; d'Agostino G; Fagotti A; Mancuso S
Prognostic significance of receptors for epidermal growth factor, estrogen, and progesterone in ovarian cancer.
Annals of the New York Academy of Sciences 1996;784():202-8.
-
1996: Maurizi M; Almadori G; Cadoni G; Scambia G; Ottaviani F; Ferrandina G; Paludetti G; D'Abramo G; Mancuso S
Cathepsin D concentration in primary laryngeal cancer: correlation with clinico-pathological parameters, EGFR status and prognosis.
International journal of cancer. Journal international du cancer 1996;69(2):105-9.
-
1996: Scambia G; Benedetti Panici; Foti E; Ferrandina G; Leone F P; Marciano M; Mancuso S
Multiple tumour marker assays in advanced cervical cancer: relationship to chemotherapy response and clinical outcome.
European journal of cancer (Oxford, England : 1990) 1996;32A(2):259-63.
-
1996: Scambia G; Ferrandina G; Marone M; Benedetti Panici P; Giannitelli C; Piantelli M; Leone A; Mancuso S
nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):334-42.
-
1996: Bellacosa A; Almadori G; Cavallo S; Cadoni G; Galli J; Ferrandina G; Scambia G; Neri G
Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(1):175-80.
-
1995: Ranelletti F O; Scambia G; Benedetti Panici P; Piantelli M; Ferrandina G; D'Agostino G; De Vincenzo R; Rinelli A; Isola G; Mancuso S
Methyl-p-hydroxyphenyllactate-esterase activity and type-II estrogen-binding sites in ovarian cancer: correlation with biological and clinico-pathological parameters.
International journal of cancer. Journal international du cancer 1995;62(5):536-41.
-
1995: Ferrandina G; Ranelletti F O; Scambia G; Benedetti Panici P; D'Agostino G; Piantelli M; Isola G; Mancuso S
Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS).
Cancer letters 1995;96(1):123-31.
-
1995: Bellacosa A; de Feo D; Godwin A K; Bell D W; Cheng J Q; Altomare D A; Wan M; Dubeau L; Scambia G; Masciullo V; Ferrandina G; Benedetti Panici P; Mancuso S; Neri G; Testa J R
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.
International journal of cancer. Journal international du cancer 1995;64(4):280-5.
-
1995: Scambia G; Benedetti-Panici P; Ferrandina G; Distefano M; Salerno G; Romanini M E; Fagotti A; Mancuso S
Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.
British journal of cancer 1995;72(2):361-6.
-
1995: Scambia G; Benedetti Panici P; Ferrandina G; Distefano M; Romanini M E; Sica G; Mancuso S
Significance of cathepsin-D expression in uterine tumours.
European journal of cancer (Oxford, England : 1990) 1995;31A(9):1449-54.
-
1994: Scambia G; Benedetti Panici P; Foti E; Amoroso M; Salerno G; Ferrandina G; Battaglia F; Greggi S; De Gaetano A; Puglia G
Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2309-16.
-
1994: Scambia G; Gadducci A; Panici P B; Foti E; Ferdeghini M; Ferrandina G; Amoroso M; Castellani C; Facchini V; Mancuso S
Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma.
Gynecologic oncology 1994;54(3):292-7.
-
1994: Scambia G; Panici P B; Ferrandina G; Battaglia F; Sica G; Coronetta F; Rumi C; Mancuso S
Effect of recombinant human interferon-alpha/2b on epidermal-growth-factor-, estrogen- and progesterone-receptor expression in primary cervical cancer.
International journal of cancer. Journal international du cancer 1994;58(6):769-73.
-
1994: Scambia G; Catozzi L; Benedetti Panici P; Ferrandina G; Almadori G; Paludetti G; Cadoni G; Distefano M; Piffanelli A; Mancuso S
Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors.
British journal of cancer 1994;69(6):995-9.
-
1994: Battaglia F; Scambia G; Panici P B; Castelli M; Ferrandina G; Foti E; Amoroso M; D'Andrea G; Mancuso S
Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancer.
Gynecologic oncology 1994;53(2):176-82.
-
1994: Scambia G; Panici P B; Ranelletti F O; Ferrandina G; De Vincenzo R; Piantelli M; Masciullo V; Bonanno G; Isola G; Mancuso S
Quercetin enhances transforming growth factor beta 1 secretion by human ovarian cancer cells.
International journal of cancer. Journal international du cancer 1994;57(2):211-5.
-
1994: Scambia G; Benedetti Panici P; Ferrandina G; Battaglia F; Distefano M; D'Andrea G; De Vincenzo R; Maneschi F; Ranelletti F O; Mancuso S
Significance of epidermal growth factor receptor expression in primary human endometrial cancer.
International journal of cancer. Journal international du cancer 1994;56(1):26-30.
-
1994: Scambia G; Panici P B; Ferrandina G; Salerno G; D'Agostino G; Distefano M; de Vincenzo R; Ercoli A; Mancuso S
Clinical significance of cathepsin D in primary ovarian cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(7):935-40.
-
1994: Scambia G; Ranelletti F O; Panici P B; De Vincenzo R; Bonanno G; Ferrandina G; Piantelli M; Bussa S; Rumi C; Cianfriglia M
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target.
Cancer chemotherapy and pharmacology 1994;34(6):459-64.
-
1993: Scambia G; Catozzi L; Benedetti-Panici P; Ferrandina G; Battaglia F; Giovannini G; Distefano M; Pellizzola D; Piffanelli A; Mancuso S
Expression of ras p21 oncoprotein in normal and neoplastic human endometrium.
Gynecologic oncology 1993;50(3):339-46.
-
1993: Scambia G; Ranelletti F O; Panici P B; Piantelli M; De Vincenzo R; Ferrandina G; Bonanno G; Capelli A; Mancuso S
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines.
International journal of cancer. Journal international du cancer 1993;54(3):462-6.
-
1993: Ferrandina G; Scambia G; Benedetti Panici P; Ranelletti F O; De Vincenzo R; Piantelli M; Distefano M; Capelli A; Mancuso S
Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptor.
Gynecologic oncology 1993;49(1):67-72.
-
1993: Scambia G; Catozzi L; Panici P B; Ferrandina G; Coronetta F; Barozzi R; Baiocchi G; Uccelli L; Piffanelli A; Mancuso S
Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factor.
American journal of obstetrics and gynecology 1993;168(1 Pt 1):71-8.
-
1992: Ferrandina G; Scambia G; Benedetti Panici P; Almadori G; Paludetti G; Cadoni G; Distefano M; Maurizi M; Mancuso S
Cathepsin D in primary squamous laryngeal tumors: correlation with clinico-pathological parameters and receptor status.
Cancer letters 1992;67(2-3):133-8.
-
1992: Maurizi M; Scambia G; Benedetti Panici P; Ferrandina G; Almadori G; Paludetti G; De Vincenzo R; Distefano M; Brinchi D; Cadoni G
EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significance.
International journal of cancer. Journal international du cancer 1992;52(6):862-6.
-
1992: Scambia G; Ranelletti F O; Benedetti Panici P; Piantelli M; Bonanno G; De Vincenzo R; Ferrandina G; Maggiano N; Capelli A; Mancuso S
Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (II).
Gynecologic oncology 1992;45(1):13-9.
-
1992: Scambia G; Benedetti Panici P; Battaglia F; Ferrandina G; Baiocchi G; Greggi S; De Vincenzo R; Mancuso S
Significance of epidermal growth factor receptor in advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):529-35.
-
1992: Ferrandina G; Scambia G; Benedetti Panici P; Bonanno G; De Vincenzo R; Rumi C; Bussa S; Genuardi M; Romano Spica V; Mancuso S
Effects of dexamethasone on the growth and epidermal growth factor receptor expression of the OVCA 433 ovarian cancer cells.
Molecular and cellular endocrinology 1992;83(2-3):183-93.
-
1992: Scambia G; Ranelletti F O; Benedetti Panici P; Piantelli M; De Vincenzo R; Bonanno G; Ferrandina G; Isola G; Mancuso S
Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumours.
European journal of cancer (Oxford, England : 1990) 1992;28A(11):1885-9.
-
1991: Scambia G; Benedetti Panici P; Ferrandina G; Battaglia F; Rossi S; Bellantone R; Crucitti F; Mancuso S
Cathepsin D and epidermal growth factor in human breast cyst fluid.
British journal of cancer 1991;64(5):965-7.
-
1991: Scambia G; Benedetti P; Ferrandina G; Battaglia F; Baiocchi G; Mancuso S
Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.
British journal of cancer 1991;64(1):182-4.
-
1991: Scambia G; Panici P B; Battaglia F; Ferrandina G; Almadori G; Paludetti G; Maurizi M; Mancuso S
Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors.
Cancer 1991;67(5):1347-51.
-
1991: Scambia G; Ranelletti F O; Benedetti Panici P; Piantelli M; Bonanno G; De Vincenzo R; Ferrandina G; Pierelli L; Capelli A; Mancuso S
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites.
Cancer chemotherapy and pharmacology 1991;28(4):255-8.
-
1991: Scambia G; Panici P B; Battaglia F; Ferrandina G; Baiocchi G; Gallo A; Sica G; Mancuso S
Effect of recombinant human interferon-alpha 2b on receptors for steroid hormones and epidermal growth factor in patients with endometrial cancer.
European journal of cancer (Oxford, England : 1990) 1991;27(1):51-3.
-
1990: Scambia G; Ranelletti F O; Panici P B; Piantelli M; Bonanno G; De Vincenzo R; Ferrandina G; Rumi C; Larocca L M; Mancuso S
Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells.
British journal of cancer 1990;62(6):942-6.
-
1990: Ferrandina G; Scambia G; Ranelletti F O; Benedetti Panici P; Battaglia F; Mancuso S
Morphological changes induced by epidermal growth factor and estradiol on CG5 human breast cancer cell line: a scanning electron microscopy study.
Anticancer research 1990;10(4):991-4.
-
1990: Scambia G; Panici P B; Baiocchi G; Battaglia F; Ferrandina G; Greggi S; Mancuso S
Steroid hormone receptors in carcinoma of the cervix: lack of response to an antiestrogen.
Gynecologic oncology 1990;37(3):323-6.
-
1990: Scambia G; Panici P B; Iacobelli S; Baiocchi G; Battaglia F; Perrone L; Sonsini C; Ferrandina G; Natoli C; Mancuso S
Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignancies.
Cancer 1990;65(6):1325-8.
-
1989: Scambia G; Panici P B; Battaglia F; Ferrandina G; Gaggini C; Mancuso S
Growth inhibitory effect of diheptyl diselenide on various human cancer cell lines.
Anticancer research 1989;9(6):1697-9.
-
1989: Battaglia F; Rossi S; Scambia G; Lanzone A; Benedetti-Panici P; Ferrandina G; Lombardi C P; Bellantone R; Crucitti F; Mancuso S
Epidermal growth factor levels in human breast cyst fluid.
Anticancer research 1989;9(6):1661-3.
-
1988: Battaglia F; Scambia G; Provenzano C; Rossi S; Benedetti Panici P; Ferrandina G; Bartoccioni E; Crucitti F; Mancuso S
Receptor for epidermal growth factor in neoplastic and non-neoplastic human thymus.
Annals of the New York Academy of Sciences 1988;551():366-8.
Sign-in to see more
